In order to evaluate the suitability of l-carnitine (LC) as an anti-wasting agent for clinical purposes the present review comprehensively summarizes the results from animal and clinical studies showing the effects of supplementation with LC or LC derivatives (acetyl-LC, propionyl-LC) on critical mechanisms involved in skeletal muscle loss under pathologic conditions, such as increased proteolysis, impaired protein synthesis, myonuclear apoptosis, inflammation, oxidative stress, and mitochondrial dysfunction
Where Retatrutide Now Sits vs the Competition Cross-trial comparisons have limitations, but the magnitude gaps are large enough to draw conclusions: Retatrutide at 12 mg produces the largest weight loss of any published Phase 3 GLP-1-class compound
If you are comparing tirzepatide and semaglutide , shelf life and storage convenience are worth considering alongside efficacy and side effect profiles
The answer is unequivocally yes
28.3% weight loss at 80 weeks